Inhibitor Therapeutics Appoints Dr. Debra Peattie to its Board of Directors
October 31, 2019 at 12:55 pm
INHIBITOR Therapeutics Inc. announced that Debra Peattie, PhD, MBA has been appointed as an independent member of its Board of Directors. Dr. Peattie is a veteran life science entrepreneur who previously served as Senior Director in the Future Pipelines Discovery Division of GlaxoSmithKline, where she focused on translating early-stage science into novel therapeutics within GSK's Discovery Partnerships with Academia initiative.